Evolus
EOLS
106 hedge funds and large institutions have $77.1M invested in Evolus in 2019 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 23 closing their positions.
65% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 23
60% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 20
13% more funds holding
Funds holding: 94 → 106 (+12)
4.9% more ownership
Funds ownership: 14.45% → 19.35% (+4.9%)
14% less capital invested
Capital invested by funds: $89.2M → $77.1M (-$12.1M)
43% less call options, than puts
Call options by funds: $4.42M | Put options by funds: $7.76M
Top Buyers
| 1 |
AAM
Aureus Asset Management
Boston,
Massachusetts
|
+$6.63M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.65M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.45M |
| 4 |
Millennium Management
New York
|
+$3.07M |
| 5 |
MP
MFN Partners
Boston,
Massachusetts
|
+$2.38M |
Top Sellers
EOLS Hedge Fund Activity: Q2 2019 in Review
106 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Evolus (EOLS) for Q2 2019, worth a combined $77.1M — down 14% from $89.2M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new EOLS positions and 23 closed out — a net gain of 15 holders — while 32 added to existing stakes and 20 trimmed.
The largest buyer was Aureus Asset Management, adding an estimated $6.63M. The largest seller was Credit Suisse, exiting entirely with an estimated $2.5M sold.
- 106 institutional investors held Evolus (EOLS) as of Q2 2019, up from 94 in Q1 2019.
- Funds reported $77.1M of Evolus stock for Q2 2019, down 14% quarter-over-quarter.
- 38 funds opened new Evolus positions in Q2 2019 and 23 closed out, a net change of +15 holders.
- The largest Evolus buyer in Q2 2019 was Aureus Asset Management, an estimated $6.63M added.
- The largest Evolus seller in Q2 2019 was Credit Suisse, an estimated $2.5M sold.
Based on aggregated 13F filings for Q2 2019.